Главная страницаLBank Stocks
JIN MEDICAL INTERNATIONAL LTD. Обыкновенные акции
JIN MEDICAL INTERNATIONAL LTD. Обыкновенные акции

JIN MEDICAL INTERNATIONAL LTD. Обыкновенные акции (ZJYL)

24HВысокий$1.9124HНизкий$1.90
$1.91
+0.00%

Последнее обновление: 2026-10-30 10:12:06

Симуляция графика K-линий, фактические данные указаны на торговой странице

Ключевые данные

Открытие вчера
$1.91
Пред. закрытие
$1.91
Вчерашний диапазон
$1.90 - $1.91
Диапазон 52 нед.
$1.53 - $5.78
Объем торговли
617
МС
$141.86M
P/E
10.6x
EPS
$0.18

Обзор компании

NASDAQ

Jin Medical International Ltd. проектирует и производит инвалидные коляски и вспомогательные средства для повседневной жизни.

СекторЗДРАВООХРАНЕНИЕ
ОтрасльМЕДИЦИНСКИЕ ИНСТРУМЕНТЫ И ПРИНАДЛЕЖНОСТИ
Штаб-квартира№ 33, улица Линсян, Чанчжоу, Китай
СтранаСША
Дата листинга2023-03-28
Конец финансового года2026-06-30
Акции в обращении73.663M
Код CIK1837821

Финансовые показатели

Индикатор2026-06-302025-12-312025-06-302025-03-31
Доход$8.919M$10.806M$4.941M$9.882M
Операционные расходы$6.522M$7.164M$3.674M$7.348M
Чистая прибыль-$107.735K$1.28M-$44.504K-$89.008K
Чистая рентабельность-1.2%11.8%-0.9%-0.9%
Прибыль на акцию--------
EBITDA-$480.542K$1.198M-$161.476K-$322.952K
Эффективная налоговая ставка31.5%12.4%68.5%68.5%

Часто задаваемые вопросы

ZJYL operates in the [sector name] industry, specializing in [core business activities]. The company primarily generates revenue through [main revenue drivers], such as [specific operations, products, or services]. Its focus on [key business strength] has positioned it as a significant player within its market.
ZJYL is part of the [sector name] and operates within the [specific industry name]. The company benefits from growth opportunities such as [list specific opportunities], while facing risks including [list pertinent risks like competition, economic factors, or regulation]. Investors should evaluate both these factors before considering ZJYL.
ZJYL's dividend policy depends on its financial performance and strategic priorities. Currently, it [pays/not pays] dividends, reflecting its [reinvestment focus or shareholder returns strategy]. Investors should consult the latest earnings reports for updates on dividend decisions.
ZJYL competes with companies like [key competitors] in the [specific industry]. Its business model emphasizes [unique strengths, e.g., innovation, scalability], giving it [competitive advantages]. However, competition in this sector can be intense, requiring ZJYL to continuously adapt and invest.
Investors should evaluate metrics such as ZJYL's revenue growth, profit margin, earnings per share (EPS), and valuation ratios. These provide insights into its profitability and market standing. Monitoring quarterly earnings reports can help gauge its financial health over time.
ZJYL's stock performance has been influenced by [specific industry trends, regulatory changes, or company developments]. For example, [mention major news or shifts]. Such changes highlight the need for investors to stay updated on company-specific and broader industry factors.
Shareholders of ZJYL are exposed to risks like [list key risks, such as market volatility, regulatory changes, shifts in demand]. Additionally, macroeconomic factors could affect [specific aspects of its industry or market position]. Proper diversification can help mitigate these risks.
ZJYL’s valuation depends on factors like its price-to-earnings (P/E) ratio and growth expectations. Measuring against industry peers can offer insights into whether its stock is overvalued or undervalued. Investors should combine these metrics with broader market trends for a better perspective.
Предупреждение о рисках
  1. 1.Цены на акции могут сильно колебаться, инвестируйте осторожно. Прошлые результаты не гарантируют будущую доходность.
  2. 2.Торговля цифровыми активами сопряжена с рыночными, техническими и иными рисками. Пожалуйста, принимайте взвешенные решения и рационально распределяйте активы.
  3. 3.Информация на этой странице предназначена только для ознакомления и не является инвестиционной рекомендацией.